Terms: = Lymphoma AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Diagnosis
137 results:
1. Predictive factors and scoring system for intravascular large B-cell lymphoma among suspected cases: a single-center retrospective analysis.
Tanaka M; Miyagaki T; Okano T; Takeuchi S; Kadono T
Int J Dermatol; 2024 Jan; 63(1):79-84. PubMed ID: 37955167
[TBL] [Abstract] [Full Text] [Related]
2. Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with fever.
Kanda N; Yamaguchi R; Yamamoto Y; Matsumura M; Hatakeyama S
Sci Rep; 2023 Nov; 13(1):18784. PubMed ID: 37914769
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy.
Shirouchi Y; Nishimura N; Mishima Y; Ishihara Y; Asai H; Tamba M; Hirano M; Hirano K; Teramoto Y; Yoshida K; Takeuchi K; Terauchi T; Maruyama D
Sci Rep; 2023 Aug; 13(1):13713. PubMed ID: 37608029
[TBL] [Abstract] [Full Text] [Related]
4. Clinical features and images of malignant lymphoma localized in the pancreatic head to differentiate from pancreatic ductal adenocarcinoma: a case series study.
Kato N; Yamaguchi A; Sugata S; Hamada T; Furuya N; Mizumoto T; Tamaru Y; Kusunoki R; Kuwai T; Kouno H; Tazuma S; Sudo T; Kido M; Ito T; Kuraoka K; Kohno H
BMC Gastroenterol; 2023 May; 23(1):138. PubMed ID: 37127562
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of serum sil-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma.
Hirami Y; Nishimura MF; Urata T; Morimoto M; Maekawa Y; Yoshino T; Nishimura Y; Sato Y
J Clin Exp Hematop; 2023 Mar; 63(1):25-31. PubMed ID: 36843068
[TBL] [Abstract] [Full Text] [Related]
6. Usefulness of Serum Soluble Interleukin-2 Receptor Levels for Differentiating between PCNSL and SCNSL.
Mitobe Y; Matsuda KI; Sonoda Y
Neurol Med Chir (Tokyo); 2023 Mar; 63(3):111-115. PubMed ID: 36682790
[TBL] [Abstract] [Full Text] [Related]
7. Miliary tuberculosis-associated hemophagocytic lymphohistiocytosis with a high level of soluble interleukin-2 receptor successfully treated with concomitant recombinant thrombomodulin: A case report.
Uryu H; Nakamura T; Nakashima D; Yamamoto K; Honda Y; Ishikawa M; Tsujita T; Hata N; Oinuma T; Yamazaki H; Yahagi Y
J Infect Chemother; 2023 Mar; 29(3):361-366. PubMed ID: 36481565
[TBL] [Abstract] [Full Text] [Related]
8. Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma.
Suzuki K; Namba K; Kase S; Ogino Y; Hase K; Iwata D; Mizuuchi K; Hiraoka M; Kitaichi N; Ishida S
BMC Ophthalmol; 2022 Nov; 22(1):428. PubMed ID: 36357882
[TBL] [Abstract] [Full Text] [Related]
9. Mapping the genetic features of T-ALL cases through simplified NGS approach.
García-Aznar JM; Alonso S; Iglesias DU; de Ugarriza PL; López CÁ; Balbín M; Del Castillo TB
Clin Immunol; 2022 Dec; 245():109151. PubMed ID: 36270471
[TBL] [Abstract] [Full Text] [Related]
10. [A Case of Angioimmunoblastic T-cell lymphoma (AITL)].
Kaneoka A; Akamatsu Y; Hara R; Sugiyama A; Setoguchi M
J UOEH; 2022; 44(3):293-299. PubMed ID: 36089348
[TBL] [Abstract] [Full Text] [Related]
11. Serum cell-free DNA concentration as a possible prognostic marker in newly diagnosed diffuse large B-cell lymphoma.
Shirouchi Y; Mishima Y; Takayama T; Minowa S; Ishihara Y; Tamba M; Hirano M; Onda N; Takeuchi K; Maruyama D
Biomed Res; 2022; 43(4):99-106. PubMed ID: 35989290
[TBL] [Abstract] [Full Text] [Related]
12. sil-2R: A Novel Diagnostic Biomarker for Primary Adrenal lymphoma.
Yu K; Xie W; Zhao L; Wang H; Ren Y; Zheng C; Chen X; Su Z; Tang Y; Zhou F; Tian H; Zhu Y; Chen T
J Clin Endocrinol Metab; 2022 May; 107(6):e2284-e2290. PubMed ID: 35254444
[TBL] [Abstract] [Full Text] [Related]
13. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of serum levels of selected cytokine receptors in adult B-cell precursor acute lymphoblastic leukemia and their association with prognostic factors and survival.
Horacek JM; Kupsa T; Vanek J; Jakl M; Stajer M; Jebavy L; Zak P
Exp Oncol; 2021 Sep; 43(3):234-236. PubMed ID: 34591424
[TBL] [Abstract] [Full Text] [Related]
15. [Analysis of Predictive Value of Laboratory Indexes for Malignant lymphoma Patients with Bone Marrow Involvement].
Zhu TG; Li YH; Zhang FH; Han J; DU XL; Zhang XJ; Wei B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):763-771. PubMed ID: 34105470
[TBL] [Abstract] [Full Text] [Related]
16. Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with probable mesentery involvement with associated hemophagocytic syndrome (HPS) - how to treat it?
Giza A; Gałązka K; Jońca M; Raźny M; Zimowska-Curyło D; Wilk M; Goldman-Mazur S; Piątkowska-Jakubas B; Sacha T
J Dermatolog Treat; 2022 Aug; 33(5):2674-2676. PubMed ID: 32924664
[TBL] [Abstract] [Full Text] [Related]
17. Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.
Ishiguro K; Sasaki Y; Takagi Y; Niinuma T; Suzuki H; Tokino T; Hayashi T; Takahashi T; Igarashi T; Matsuno Y
Medicine (Baltimore); 2020 Aug; 99(35):e21938. PubMed ID: 32871937
[TBL] [Abstract] [Full Text] [Related]
18. Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemia.
Moriguchi M; Koh H; Hayashi T; Okamura H; Nanno S; Nakashima Y; Nakane T; Imoto W; Yamada K; Kakeya H; Hino M; Nakamae H
J Infect Chemother; 2020 Oct; 26(10):1054-1057. PubMed ID: 32505444
[TBL] [Abstract] [Full Text] [Related]
19. High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era.
Mozas P; Rivas-Delgado A; Rivero A; Dlouhy I; Nadeu F; Balagué O; González-Farré B; Baumann T; Giné E; Delgado J; Villamor N; Campo E; Pérez-Galán P; Filella X; Magnano L; López-Guillermo A
Leuk Res; 2020 Jul; 94():106371. PubMed ID: 32473488
[TBL] [Abstract] [Full Text] [Related]
20. Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma.
Nozaki K; Sugahara H; Ueda S; Ishikawa J; Fuji S; Masaie H; Tada Y; Karasuno T; Iida M; Mitsui H; Kamae T; Saito N; Moriyama Y; Kawakami M; Kato R; Nakae Y; Kida T; Kosugi S; Nakagawa M; Uchida Y; Azenishi Y; Sakaniwa R; Kitamura T; Shibayama H
Leuk Lymphoma; 2020 Sep; 61(9):2113-2121. PubMed ID: 32366194
[TBL] [Abstract] [Full Text] [Related]
[Next]
